Sham Neuro RX Gamma device

DEVICE2 trials

Sponsors

Vielight Inc., Unity Health Toronto

Conditions

Alzheimer DiseaseAmnestic Mild Cognitive DisorderMCI

Early Phase 1

Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI)

CompletedNCT05563298

Unity Health TorontoAmnestic Mild Cognitive Disorder, MCI

Start: 2023-03-28End: 2025-02-03Updated: 2025-07-24

Unknown Phase

Neuro RX Gamma - Pivotal Phase

SuspendedNCT03484143

Vielight Inc.Alzheimer Disease

Start: 2019-06-26End: 2023-05-31Target: 228Updated: 2023-01-25

Related Papers

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial.

2026-06-03